Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» filgotinib
filgotinib
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
Gilead gets ball rolling on JAKs game in Japan
Endpoints
Mon, 12/30/19 - 10:39 am
Gilead Sciences
Japan
filgotinib
Eisai
rheumatoid arthritis
As promised, Gilead and Galapagos file filgotinib to FDA and get a speedy review
Fierce Biotech
Fri, 12/20/19 - 12:29 pm
Gilead Sciences
FDA
filgotinib
Galapagos
rheumatoid arthritis
Gilead’s filgotinib fails midphase tests in lupus, Sjogren's
Fierce Biotech
Fri, 10/25/19 - 10:39 am
Gilead Sciences
filgotinib
lupus
Sjögren’s syndrome
clinical trials
Gilead, Galapagos share 52-week update on filgotinib
Fierce Biotech
Fri, 10/11/19 - 10:44 am
Gilead Sciences
Galapagos
filgotinib
clinical trials
rheumatoid arthritis
Chasing AbbVie, Gilead files for approval of filgotinib in Japan
Fierce Biotech
Tue, 10/8/19 - 09:40 am
Gilead Sciences
JAK inhibitors
Japan
filgotinib
Galapagos
AbbVie
Watch out AbbVie: Gilead is fast on your heels at the FDA with rival JAK inhibitor filgotinib
Endpoints
Tue, 07/2/19 - 10:46 am
Gilead Sciences
AbbVie
FDA
JAK inhibitors
filgotinib
Upadacitinib
rheumatoid arthritis
Upcoming events – Crucial data on zanubrutinib and filgotinib approach
EP Vantage
Fri, 06/14/19 - 10:14 am
BeiGene
Waldenström’s macroglobulinemia
zanubrutinib
Galapagos
filgotinib
CLE
Sjögren’s syndrome
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Sun, 05/5/19 - 10:34 am
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
Gilead earns needed trial win as arthritis drug succeeds in 2 studies
Biopharma Dive
Thu, 03/28/19 - 11:38 pm
Gilead Sciences
filgotinib
clinical trials
FDA
2 Biotech Stocks With Major Incoming Catalysts
Yahoo/Motley Fool
Thu, 03/7/19 - 09:52 am
Axsome Therapeutics
AXS-05
depression
Galapagos
filgotinib
Gilead Sciences
rheumatoid arthritis
Could Gilead and Galapagos' JAK inhibitor lead the class? Wall Street thinks it has a chance.
Biopharma Dive
Mon, 11/26/18 - 11:13 pm
Gilead Sciences
Galapagos
JAK inhibitors
rheumatoid arthritis
filgotinib
A Brawl Is Brewing Between AbbVie and Gilead Sciences in Arthritis
Yahoo/Motley Fool
Fri, 09/14/18 - 09:36 am
AbbVie
Gilead Sciences
FDA
rheumatoid arthritis
Upadacitinib
filgotinib
What's Next for Gilead Sciences After Its Latest Clinical Success
Motley Fool
Thu, 09/13/18 - 12:00 pm
Gilead Sciences
John Milligan
HIV
NASH
filgotinib
Galapagos shares surge on RA drug trial results
Pharmaforum
Thu, 09/13/18 - 10:02 am
Gilead Sciences
Galapagos
filgotinib
rheumatoid arthritis
clinical tgrials
Gilead, Galapagos clear another PhII hurdle for filgotinib, but can they hope to catch up with Novartis’ Cosentyx?
Endpoints
Thu, 09/6/18 - 10:15 am
Gilead Sciences
Galapagos
filgotinib
Novartis
Cosentyx
ankylosing spondylitis
Jefferies says Gilead is poised for turnaround—and JAK inhibitor could be key
Fierce Biotech
Thu, 07/5/18 - 07:42 pm
Gilead Sciences
JAK inhibitors
filgotinib
rheumatoid arthritis
Gilead, Galapagos hit goal in psoriatic arthritis phase 2
Fierce Biotech
Thu, 05/31/18 - 09:33 am
Gilead Sciences
Galapagos
filgotinib
psoriatic arthritis
clinical trials
ulcerative colitis
5 Drugs That Are Critical for Gilead Sciences' Future
Motley Fool
Thu, 02/22/18 - 09:18 am
Gilead Sciences
Biktarvy
Yescarta
selonsertib
filgotinib
Epclusa
Galapagos snags co-promotion rights on filgotinib — just before Gilead’s lock-up pact expires
Endpoints
Thu, 12/14/17 - 09:24 pm
Galapagos
Gilead Sciences
filgotinib
Pages
« first
‹ previous
1
2
3
next ›
last »